Perazine

DB12710ApprovedWithdrawnSmall molecule

Perazine is a phenothiazine antipsychotic used in the acute and chronic treatment of psychotic disorders. Perazine has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.

Chemical structure of Perazine
Formula / weight
C20H25N3S · 339.5 g/mol (avg)

Resolves to

Compound
UNII8915147A2BCAS84-97-9ChEMBLCHEMBL1697766ChEBI59118PubChem4744KEGGC16903
Clinical / RWD
RxNorm8042ATCN05AB10PharmGKBPA162565876
Structure
InChIKeyWEYVCQFUGFRXOM-UHFFFAOYSA-NSMILESCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=CC=C23)CC1
Targets
P14416DRD2

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
838Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
11Marketed productsAcross every region we cover
Sign in
1ATC codeIncluding every combination product, plus 15 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Perazine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In